Maximizing Value in the Pharmacy Revenue Cycle
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Maximizing Value in the Pharmacy Revenue Cycle
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of The Innovators Podcast, host Jim Jorgenson is joined by pharmacy revenue cycle experts Maxie Friemel and Tim Miller to explore the often underestimated, and increasingly critical, world of pharmacy finances. The conversation goes well beyond billing, diving into key issues such as prior authorizations, denials, biosimilar adoption, charge structures, and payer audits.
For hospital and health system leaders, the pharmacy revenue cycle presents both significant risk and opportunity. As specialty drug costs rise and payer scrutiny intensifies, understanding pharmacy’s role in financial performance is more important than ever. Maxie and Tim share practical insights to help leaders foster collaboration across pharmacy, finance, compliance, and IT, improve charge capture, and drive clean claims.
Packed with actionable strategies and big-picture thinking, this is a must-listen episode for any hospital leader focused on strengthening financial sustainability and operational alignment.